Not a good buy right now for an impatient buyer: price action is in a clear downtrend and momentum is still deteriorating.
Despite being extremely oversold (bounce potential), the stock is trading below key support (~19.05) and options flow skews defensive/bearish near-term.
Better setup is likely after stabilization (reclaiming ~$19.05–$21.79) or post-earnings (2026-02-24) rather than buying into a falling trend.
Technical Analysis
Trend: Bearish. Moving averages are stacked negatively (SMA_200 > SMA_20 > SMA_5), consistent with sustained downside.
Momentum: MACD histogram -0.546 and negatively expanding, suggesting bearish momentum is still strengthening.
RSI: RSI_6 at 3.978 = extremely oversold, which can fuel a sharp reflex bounce, but does not confirm a bottom by itself.
Levels: Current ~18.18 is below S1 (19.046), making ~19.05 an important reclaim level. Next support S2 ~17.354. Overhead pivot resistance ~21.785 (then R1 ~24.524).
Pattern/stat read: Similar-pattern analysis implies a 70% chance of -2.54% next day, but +2.32% next week and +5.5% next month (near-term pressure, medium-term rebound potential).
Options Data
Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio
Positioning vs flow: OI put/call 0.42 (more call OI outstanding), but put/call volume 10.4 shows today’s trading flow is heavily put-dominant (near-term bearish/hedging tone).
Volatility: 30D IV ~78% vs HV ~55% (options priced rich), IV percentile ~67 suggests elevated IV relative to its recent history.
Activity: Total volume 57 (calls 5 vs puts 52); today volume ~78% of 30D avg (not a major spike). Open interest 2,487 and ~131% vs avg indicates positioning has built up recently.
Takeaway: Sentiment is mixed overall (call-heavy OI), but the near-term tape is skewed bearish/defensive (put-heavy volume).
Technical Summary
Sell
9
Buy
6
Positive Catalysts
Extremely oversold RSI can trigger a fast technical bounce if selling pressure eases.
Hedge funds are accumulating: buying amount up 158.11% over the last quarter (supportive medium-term).
Strong last reported quarter growth trends (revenue, earnings, EPS all up strongly YoY).
Earnings catalyst: QDEC 2025 earnings on 2026-02-24 after hours (can reset narrative if results/guide are strong).
Recent Wall St action: JPMorgan (2025-12-12) raised price target to $32 from $30 and maintained Overweight.
Pros (Street view): Higher PT and Overweight imply meaningful upside from current levels if execution continues; aligns with strong YoY growth in the latest quarter.
Cons (Street view): Current market tape is decisively bearish; near-term sentiment (put-heavy volume) suggests traders are bracing for more downside/volatility into the next catalyst (earnings).
Influential/political trading: No recent congress trading data available; insiders are neutral with no significant recent trend.
Wall Street analysts forecast EVER stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EVER is 35 USD with a low forecast of 32 USD and a high forecast of 40 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast EVER stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EVER is 35 USD with a low forecast of 32 USD and a high forecast of 40 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 17.240
Low
32
Averages
35
High
40
Current: 17.240
Low
32
Averages
35
High
40
JPMorgan
NULL -> Overweight
maintain
$30 -> $32
AI Analysis
2025-12-12
Reason
JPMorgan
Price Target
$30 -> $32
AI Analysis
2025-12-12
maintain
NULL -> Overweight
Reason
JPMorgan raised the firm's price target on EverQuote to $32 from $30 and keeps an Overweight rating on the shares. The firm adjusted ratings and targets in the small- and mid-cap internet and video games group as part of its 2026 outlook.
Raymond James
Strong Buy -> Outperform
downgrade
$35 -> $30
2025-09-22
Reason
Raymond James
Price Target
$35 -> $30
2025-09-22
downgrade
Strong Buy -> Outperform
Reason
Raymond James downgraded EverQuote to Outperform from Strong Buy with a price target of $30, down from $35. The firm sees the company's revenue growth decelerating year-over-year in Q3 and beyond as its prior year period comps normalize. EverQuote's revenue growth could moderate to a high single-digit rate by fiscal 2027, which is below management's target, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for EVER
